# Release Readiness

## Agent

- Name: Cloud landing zone specialist
- Domain: Cloud Platform And Infrastructure
- Release version: v1.1.0
- Issue: #1634
## Readiness Gates

- [x] Specialty boundary is explicit and rejects adjacent application, non-cloud, live execution, legal/compliance signoff, MLOps, IAM lawyering, DNS/migration execution, and vendor-operations ownership.
- [x] Research summary is present and aligned to research contract `2026-04-08`.
- [x] Functionality map is present and covers all required shared, workflow-phase, and cross-industry abilities.
- [x] Authority sources are current as of 2026-04-14 and include refresh intervals and decay policies.
- [x] Evaluation thresholds are met: 18 scenarios, 18 passes, pass rate 1.00, minimum pass rate 0.90.
- [x] Human verification is recorded in structured readiness evidence.
- [x] Deployment, rollback, tenant isolation, materialization, monitoring, and logging notes are documented.
- [x] Commercialization positioning, subscription model, proof points, and go-to-market gaps are documented.
- [x] No retained implementation is claimed; the package remains the canonical spec pack for runtime materialization.

## Release Decision

- Decision: Approve for validated spec-pack release claim
- Reviewer: John (Lead Platform Engineer)
- Date: 2026-04-14
- Notes: The refreshed package supersedes the committed legacy baseline as source of truth. It remains scoped to cloud landing-zone architecture, guardrails, IaC guidance, operations runbooks, dependency handoffs, blocker escalation, and routing. Direct production execution and final approval authority remain outside the lane.

## Residual Risks

- Tenant jurisdiction, regulatory, contractual, privacy, and data-residency rules can materially alter recommendations and must be supplied or retrieved at runtime.
- Provider documentation may change before the next refresh interval; materializers must honor source decay policies.
- Commercial proof remains package-level; retained built runtime promotion requires frequent-use evidence and a separate human-approved promotion decision.
